Скачать
Placement of once-a-week DPP4 inhibitors in Management of T2DM RSSDI Conference @Kochi Queries
Автор: Zuventus Healthcare Limited
Загружено: 2025-11-10
Просмотров: 99
Описание:
Placement of once-a-week DPP4 inhibitors in Management of T2DM
RSSDI Conference @Kochi, 8 November 2025
For the first time in India. Zuventus has launched a brand of Trelagliptin, an once-weekly Oral DPP4i with the objective to enhance patient adherence.
Trelagliptin is approved for the treatment & management of Type 2 Diabetes Mellitus (T2DM).
The live session was addressed by eminent Endocrinologist Dr. A. H. Zargar (Srinagar) & 200+ audiences witnessed the emphatic session, followed by multiple queries over the acceptance & placement of QW drugs in T2DM management.
Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
